Bis(4-(methoxycarbonyl)phenyl) terephthalate, 98+%, 25g

ETHYL 4-(1,3-DIOXOISOINDOLIN-2-YL)-3-OXOBUTANOATE, 95.0%, 1g

Methyl 6-fluorosalicylate, 98.0%, 100g

4-Phenyl-1-butanol, 97.0%, 25g

4-Chlorophenol, >=98%, for synthesis, 250 g, glass packaging

(3-Trifluoromethyl-1H-pyrazol-4-yl)methanol, 95.0%, 250mg

GC capillary column ROTI®Cap-1701 MS, 60 m, 0.32 mm, 0.25 µm, 1 Piece(s)

4-(Methylthio)benzaldehyde, 97.0%, 250g

1-(5-ETHYLPYRIMIDIN-2-YL)PIPERIDIN-4-YL METHANESULFONATE, 90.0%, 100mg

Piperidine-1-carbonitrile>98.0%(GC)5g

1-Methyl-4-(trifluoromethyl)naphthalene, 90.0%, 250mg

{[3-(2-pyridinyl)-1,2,4-oxadiazol-5-yl]methyl}amine, 95.0%, 10g

6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]-1,4-dihydroquinazolin-4-one, 95%, 1g